Postbiotics as Antiinflammatory and Immune‐Modulating Bioactive Compounds in Metabolic Dysfunction‐Associated Steatotic Liver Disease
2024

Postbiotics for Liver Health

publication 10 minutes Evidence: moderate

Author Information

Author(s): Yilmaz Yusuf

Primary Institution: Recep Tayyip Erdoğan University

Hypothesis

Can postbiotics serve as effective therapeutic agents for metabolic dysfunction-associated steatotic liver disease (MASLD)?

Conclusion

Postbiotics show promise in treating MASLD by reducing inflammation, improving lipid metabolism, and enhancing gut health.

Supporting Evidence

  • Postbiotics can reduce liver inflammation and improve gut health.
  • These compounds may help in managing metabolic dysfunction associated with liver disease.
  • Postbiotics have a better safety profile compared to probiotics.

Takeaway

Postbiotics are good things made by bacteria that can help keep our liver healthy and reduce sickness.

Methodology

This review summarizes various postbiotics and their effects on MASLD based on preclinical studies and literature.

Limitations

Current findings are primarily based on preclinical studies, which may not fully represent human conditions.

Digital Object Identifier (DOI)

10.1002/mnfr.202400754

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication